# FDA Inspection 1070197 - Carlisle Regional Medical Center - September 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/carlisle-regional-medical-center/a96ce240-02ce-4c75-b026-a83b842d7e1a
Source feed: FDA_Inspections

> FDA Inspection 1070197 for Carlisle Regional Medical Center on September 13, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070197
- Company Name: Carlisle Regional Medical Center
- Inspection Date: 2018-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1311796 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/carlisle-regional-medical-center/15f83f48-5e9b-496b-8286-04e46ff3077d)
- [FDA Inspection 1311796 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/carlisle-regional-medical-center/81b6716c-ab9a-437c-9473-f01a24a5e50e)
- [FDA Inspection 971867 - 2016-05-04](https://www.keypedia.com/records/fda_inspections/carlisle-regional-medical-center/ce2a3739-edca-4f79-bba5-f4ab74ebb7ce)
- [FDA Inspection 878128 - 2014-05-09](https://www.keypedia.com/records/fda_inspections/carlisle-regional-medical-center/b8ded256-acd2-446a-9ae0-cca3087f706f)
- [FDA Inspection 783851 - 2012-05-30](https://www.keypedia.com/records/fda_inspections/carlisle-regional-medical-center/3d1b319b-f0ea-4ec9-9244-86ca2a92adcb)

Company: https://www.keypedia.com/companies/carlisle-regional-medical-center/cd32a472-e1fc-4080-aaf6-2922746f5c2f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d